Bicocca Open Archive

Logo unimib boa
RE, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.138
AS - Asia 10.886
EU - Europa 9.688
SA - Sud America 1.349
AF - Africa 252
OC - Oceania 187
Continente sconosciuto - Info sul continente non disponibili 17
Totale 39.517
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.342
IT - Italia 3.225
SG - Singapore 3.129
VN - Vietnam 2.297
CN - Cina 2.281
DE - Germania 1.343
HK - Hong Kong 1.140
RU - Federazione Russa 1.096
BR - Brasile 995
SE - Svezia 817
CA - Canada 643
IE - Irlanda 589
GB - Regno Unito 536
IN - India 465
FR - Francia 395
UA - Ucraina 375
BD - Bangladesh 297
FI - Finlandia 265
ID - Indonesia 190
KR - Corea 184
AU - Australia 178
PL - Polonia 174
AT - Austria 150
ES - Italia 140
NL - Olanda 129
TR - Turchia 126
AR - Argentina 121
DK - Danimarca 120
JP - Giappone 112
IQ - Iraq 107
ZA - Sudafrica 101
MX - Messico 88
PK - Pakistan 77
BE - Belgio 60
IR - Iran 60
CH - Svizzera 50
SA - Arabia Saudita 49
PH - Filippine 48
TW - Taiwan 48
UZ - Uzbekistan 48
CO - Colombia 46
VE - Venezuela 44
PT - Portogallo 40
EC - Ecuador 39
CL - Cile 35
MY - Malesia 34
RO - Romania 33
BG - Bulgaria 26
KE - Kenya 25
LT - Lituania 25
CZ - Repubblica Ceca 24
EG - Egitto 24
MA - Marocco 24
GR - Grecia 23
IL - Israele 23
PY - Paraguay 23
JO - Giordania 22
NP - Nepal 20
ET - Etiopia 17
PE - Perù 17
TN - Tunisia 17
OM - Oman 16
UY - Uruguay 16
TH - Thailandia 15
AE - Emirati Arabi Uniti 14
EU - Europa 14
AZ - Azerbaigian 12
JM - Giamaica 12
DZ - Algeria 11
HU - Ungheria 10
KZ - Kazakistan 10
AL - Albania 9
BO - Bolivia 9
PA - Panama 9
CR - Costa Rica 8
HN - Honduras 8
NZ - Nuova Zelanda 8
BB - Barbados 7
CY - Cipro 7
NI - Nicaragua 6
PS - Palestinian Territory 6
BH - Bahrain 5
DO - Repubblica Dominicana 5
LB - Libano 5
LY - Libia 5
MU - Mauritius 5
AM - Armenia 4
EE - Estonia 4
GT - Guatemala 4
KG - Kirghizistan 4
LK - Sri Lanka 4
MD - Moldavia 4
NG - Nigeria 4
NO - Norvegia 4
QA - Qatar 4
RS - Serbia 4
SN - Senegal 4
SY - Repubblica araba siriana 4
BW - Botswana 3
BY - Bielorussia 3
Totale 39.457
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.788
Singapore 1.916
Ashburn 1.683
Milan 1.235
San Jose 1.125
Hong Kong 1.090
Woodbridge 866
Frankfurt am Main 738
Ho Chi Minh City 699
Fairfield 670
Chandler 632
Houston 591
Dublin 570
Wilmington 568
Hanoi 536
New York 384
Dearborn 370
Los Angeles 369
Beijing 366
Jacksonville 362
Dallas 358
Santa Clara 358
Toronto 349
Seattle 332
Cambridge 246
Chicago 238
Hefei 194
Princeton 191
The Dalles 182
Council Bluffs 173
Nanjing 167
Rome 158
Melbourne 151
Jakarta 150
Helsinki 133
Shanghai 131
Seoul 123
Vienna 123
Lauterbourg 119
Buffalo 117
São Paulo 112
Orem 99
Boardman 94
Moscow 91
Guangzhou 87
Warsaw 75
Da Nang 74
Kraków 74
Lawrence 72
Munich 72
Tokyo 72
Columbus 71
Haiphong 68
Chennai 65
Montreal 63
San Diego 63
Altamura 62
Dong Ket 62
Ottawa 62
London 61
Denver 58
Lachine 58
Nanchang 55
Fremont 53
Brussels 52
Johannesburg 51
Atlanta 50
Monza 50
Phoenix 47
Melzo 46
Turin 45
Nuremberg 44
Hangzhou 43
Wayne 43
Baghdad 41
Brooklyn 41
Changsha 41
Pune 41
Boston 40
Kunming 40
Ha Long 39
Amsterdam 38
Bắc Ninh 38
Mumbai 38
Hải Dương 37
Poplar 37
Stockholm 37
Tashkent 37
Andover 34
Biên Hòa 33
Bologna 33
New Delhi 33
Shenyang 33
Washington 33
Zurich 33
Genoa 32
Dhaka 31
Paris 31
Turku 31
Zhengzhou 31
Totale 24.678
Salva come PNG Salva come JPEG
Nome #
Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide 730
H-Ferritin nanoparticle-mediated delivery of antibodies across a BBB in vitro model for treatment of brain malignancies 664
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 607
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 607
Differential Exchange of Multifunctional Liposomes Between Glioblastoma Cells and Healthy Astrocytes via Tunneling Nanotubes 599
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 581
The clustering of mapoe anti-amyloidogenic peptide on nanoparticle surface does not alter its performance in controlling beta-amyloid aggregation 537
An update of nanoparticle-based approaches for glioblastoma multiforme immunotherapy 534
SPRi analysis of molecular interactions of mApoE-functionalized liposomes as drug delivery systems for brain diseases 529
A new approach for glyco-functionalization of collagen-based biomaterials 529
Mesoporous silica nanoparticles trigger mitophagy in endothelial cells and perturb neuronal network activity in a size- and time-dependent manner 518
Coupling quaternary ammonium surfactants to the surface of liposomes improves both antibacterial efficacy and host cell biocompatibility 514
The Extent of Human Apolipoprotein A-I Lipidation Strongly Affects the β-Amyloid Efflux Across the Blood-Brain Barrier in vitro 489
Investigation of Functionalized Poly(N,N-dimethylacrylamide)-block-polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood-Brain Barrier in Vitro 486
Biodegradable SPI-based hydrogel for controlled release of nanomedicines: a potential approach against brain tumors recurrence 472
Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes 472
Glibenclamide-Loaded Nanoparticles Reduce NLRP3 Inflammasome Activation and Modulate miR-223-3p/miR-7-1-5p Expression in THP-1 Cells 471
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 460
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide 451
The ability of liposomes, tailored for blood-brain barrier targeting, to reach the brain is dramatically affected by the disease state 435
Phage-displayed peptides targeting specific tissues and organs 432
Nanomedicine for the treatment of Alzheimer's disease 431
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease 430
Multifunctional Liposomes Modulate Purinergic Receptor-Induced Calcium Wave in Cerebral Microvascular Endothelial Cells and Astrocytes: New Insights for Alzheimer’s disease 430
Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model 422
Nanostructured lipid carrier formulation for delivering poorly water-soluble ITF3756 HDAC inhibitor 412
Fluorimetric detection of the earliest events in amyloid β oligomerization and its inhibition by pharmacologically active liposomes 407
Nanoparticle shape is the game-changer for blood-brain barrier crossing and delivery through tunneling nanotubes among glioblastoma cells 406
Oxidative stress boosts the uptake of cerium oxide nanoparticles by changing brain endothelium microvilli pattern 406
Enhanced brain targeting of engineered solid lipid nanoparticles 405
Are the nanoparticles friends or foes when inhaled? 405
Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease 396
The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease 392
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 381
The synergistic effect of chlorotoxin-mApoE in boosting drug-loaded liposomes across the BBB 364
18F-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's disease 355
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 352
Prion protein structure is affected by pH-dependent interaction with membranes: a study in a model system 350
Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer Disease 350
TrkA pathway activation induced by amyloid-beta (Abeta) 342
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 339
Nanoparticles at the neurovascular unit: in vitro and in vivo studies to assess the blood-brain barrier permeability and function 339
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: Implications for therapy of Alzheimer disease 338
Reduced levels of ABCA1 transporter are responsible for the cholesterol efflux impairment in β‐amyloid‐induced reactive astrocytes: Potential rescue from biomimetic HDLs 337
Protein-functionalized nanoparticles derived from end-functional polymers and polymer prodrugs for crossing the blood-brain barrier 329
Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 324
Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice 324
Tat-1-liposomes to overcome the blood-brain barrier: an in vitro study 323
Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in alzheimer’s disease mouse models 322
Nanoparticles at the neurovascular unit: In vitro and in vivo studies to assess the blood-brain barrier permeability and function 319
The 3.0 cell communication: New insights in the usefulness of tunneling nanotubes for glioblastoma treatment 316
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 315
Modulation of intracellular Ca2+ concentration in brain microvascular endothelial cells actively induced by brain targeted liposomes 313
Abeta peptide toxicity is reduced after treatments decreasing phosphatidylethanolamine content in differentiated neuroblastoma cells 312
Amyposomes: a nanomedicine designed for treatment of Alzheimer disease 311
Targeting specific brain districts for advanced nanotherapies: A review from the perspective of precision nanomedicine 309
Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-β peptide: The chemical design affects the permeability across an in vitro model 309
Membrane features and activity of GPI-anchored enzymes: alkaline phosphatase reconstituted in model membranes 304
Effect of modified collagen on amyloid beta peptide aggregation 304
Effect of nanoparticles binding ß-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages 303
Molecular dynamics simulations of doxorubicin in sphingomyelin-based lipid membranes 301
A nanomedicine-based therapeutic approach restores memory and ameliorates amyloid pathology in Alzheimer's mouse models 297
Beta-amyloid (25-35) enhances lipid metabolism and protein ubiquitination in cultured neurons 293
Study of the effects of nanoliposomes engineered for the treatment of Alzheimer's disease on the electrical activity of cortical neurons 289
The fantastic voyage of solid lipid nanoparticles from the lung to the brain: non‐invasive tomographic imaging as a feasible refinement process 286
Enhanced brain targeting of engineered solid lipid nanoparticles 279
Dietary nanoparticles interact with gluten peptides and alter the intestinal homeostasis increasing the risk of celiac disease 279
Direct and indirect air pollution effects on synaptic neurotransmission linked to the development of neurodegenerative disease 278
Enhanced folate binding of cultured fibroblasts from Alzheimer's disease patients 277
Preparation and characterization of lipid-based nanoparticles binding with high affinity amyloid-beta(1-42) peptide 274
Trehalose-delivering nanoparticles improve the blood-brain barrier tightness 273
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease 273
Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide 266
In Vitro Biocompatibility and Endothelial Permeability of Branched Polyglycidols Generated by Ring-Opening Polymerization of Glycidol with B(C6F5)3 under Dry and Wet Conditions 266
Potential nanotherapeutic approach for Alzheimer's disease: in vitro clearance of beta-amyloid across the blood-brain barrier by multifunctional liposomes 263
Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice 261
Lipid-based nanoparticles with high binding affinity for amyloid-b1e42 peptide 254
Development of a 3D in vitro model mimicking the changes occurring at the blood-brain barrier during Alzheimer’s disease 254
Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity 252
Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells 248
Nanotechnology for neurodegenerative disorders 247
Synthesis of functionalized [F-18]liposomes for preclinical PET imaging in Alzheimer's disease 245
Lipid-based nanoparticles (NPs) with high binding affinity for amyloid-beta1-42 peptide modulate the barrier properties of a monolayer of endothelial cells 244
Nanoparticle-based strategy to cross the BBB: the potential for the therapy of Alzheimer’s disease 244
A novel, glutathione-activated prodrug of pimasertib loaded in liposomes for targeted cancer therapy 243
The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue 243
PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study 243
The interaction of complement system with abeta-binding liposomes: towards engineering of safer vesicles for the management of alzheimer's disease 240
Radiation and adjuvant drug-loaded liposomes target glioblastoma stem cells and trigger in-situ immune response 238
Multi-functional liposomes prevent memory impairment and slow down brain B-amyloid deposition in a mouse model of Alzheimer’s disease. 238
Dual Functionalized Liposomes for Selective Delivery of Poorly Soluble Drugs to Inflamed Brain Regions 236
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation 235
Attempt of neuroprotective response of rat cultured hippocampal neurons against Abeta insult 234
Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model 234
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 233
Nanoparticles at the neurovascular unit: in vitro and in vivo studies to assess the blood-brain barrier permeability and function 228
Applicability of [11C]PIB micro-PET imaging for in vivo follow-up of anti-amyloid treatment effects in APP23 mouse model 224
Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant 224
From the lungs to the brain: the fantastic voyage of nanoparticles targeting beta-amyloid 222
Nanotechnology for neurodegenerative disorders 217
Totale 35.118
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.933
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.933
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.187 200 204 198 209 148 188 164 136 114 164 181 281
2022/20232.938 359 818 293 295 198 432 57 140 166 33 86 61
2023/20242.332 64 81 132 161 240 542 410 117 134 55 114 282
2024/20255.643 280 461 393 305 456 370 387 224 618 855 530 764
2025/202616.817 2.445 987 1.230 1.650 1.851 744 2.207 862 1.276 1.443 923 1.199
2026/202716 16 0 0 0 0 0 0 0 0 0 0 0
Totale 40.472